XML 75 R51.htm IDEA: XBRL DOCUMENT v3.21.2
Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jul. 04, 2021
Jun. 28, 2020
Jul. 04, 2021
Jun. 28, 2020
Sales by segment of business        
Sales to customers $ 23,312 $ 18,336 $ 45,633 $ 39,027
Percent Change (as a percent) 27.10%   16.90%  
U.S.        
Sales by segment of business        
Sales to customers $ 11,919 9,539 $ 23,030 20,238
Percent Change (as a percent) 24.90%   13.80%  
International        
Sales by segment of business        
Sales to customers $ 11,393 8,797 $ 22,603 18,789
Percent Change (as a percent) 29.50%   20.30%  
Consumer Health        
Sales by segment of business        
Sales to customers $ 3,735 3,296 $ 7,278 6,921
Percent Change (as a percent) 13.30%   5.20%  
Consumer Health | U.S.        
Sales by segment of business        
Sales to customers $ 1,751 1,557 $ 3,362 3,297
Percent Change (as a percent) 12.40%   2.00%  
Consumer Health | International        
Sales by segment of business        
Sales to customers $ 1,984 1,739 $ 3,916 3,624
Percent Change (as a percent) 14.10%   8.10%  
Consumer Health | OTC        
Sales by segment of business        
Sales to customers $ 1,307 1,149 $ 2,482 2,497
Percent Change (as a percent) 13.80%   (0.60%)  
Consumer Health | OTC | U.S.        
Sales by segment of business        
Sales to customers $ 675 627 $ 1,274 1,316
Percent Change (as a percent) 7.70%   (3.20%)  
Consumer Health | OTC | International        
Sales by segment of business        
Sales to customers $ 633 522 $ 1,208 1,181
Percent Change (as a percent) 21.20%   2.30%  
Consumer Health | Skin Health/Beauty        
Sales by segment of business        
Sales to customers $ 1,170 1,007 $ 2,333 2,124
Percent Change (as a percent) 16.20%   9.80%  
Consumer Health | Skin Health/Beauty | U.S.        
Sales by segment of business        
Sales to customers $ 659 536 $ 1,293 1,195
Percent Change (as a percent) 23.00%   8.20%  
Consumer Health | Skin Health/Beauty | International        
Sales by segment of business        
Sales to customers $ 511 471 $ 1,040 929
Percent Change (as a percent) 8.40%   12.00%  
Consumer Health | Oral Care        
Sales by segment of business        
Sales to customers $ 426 397 $ 843 792
Percent Change (as a percent) 7.00%   6.30%  
Consumer Health | Oral Care | U.S.        
Sales by segment of business        
Sales to customers $ 165 170 $ 328 346
Percent Change (as a percent) (3.10%)   (5.20%)  
Consumer Health | Oral Care | International        
Sales by segment of business        
Sales to customers $ 260 227 $ 514 446
Percent Change (as a percent) 14.60%   15.30%  
Consumer Health | Baby Care        
Sales by segment of business        
Sales to customers $ 387 356 $ 776 717
Percent Change (as a percent) 8.60%   8.10%  
Consumer Health | Baby Care | U.S.        
Sales by segment of business        
Sales to customers $ 97 96 $ 193 188
Percent Change (as a percent) 0.80%   2.40%  
Consumer Health | Baby Care | International        
Sales by segment of business        
Sales to customers $ 290 260 $ 583 529
Percent Change (as a percent) 11.50%   10.20%  
Consumer Health | Women's Health        
Sales by segment of business        
Sales to customers $ 230 202 $ 452 434
Percent Change (as a percent) 13.90%   4.20%  
Consumer Health | Women's Health | U.S.        
Sales by segment of business        
Sales to customers $ 3 3 $ 6 7
Percent Change (as a percent) (3.10%)   (16.00%)  
Consumer Health | Women's Health | International        
Sales by segment of business        
Sales to customers $ 227 199 $ 446 427
Percent Change (as a percent) 14.20%   4.50%  
Consumer Health | Wound Care/Other        
Sales by segment of business        
Sales to customers $ 216 185 $ 393 356
Percent Change (as a percent) 16.60%   10.20%  
Consumer Health | Wound Care/Other | U.S.        
Sales by segment of business        
Sales to customers $ 153 126 $ 268 245
Percent Change (as a percent) 20.90%   9.30%  
Consumer Health | Wound Care/Other | International        
Sales by segment of business        
Sales to customers $ 64 59 $ 125 111
Percent Change (as a percent) 7.30%   12.10%  
PHARMACEUTICAL        
Sales by segment of business        
Sales to customers $ 12,599 10,752 $ 24,798 21,886
Percent Change (as a percent) 17.20%   13.30%  
PHARMACEUTICAL | U.S.        
Sales by segment of business        
Sales to customers $ 6,869 6,120 $ 13,315 12,181
Percent Change (as a percent) 12.20%   9.30%  
PHARMACEUTICAL | International        
Sales by segment of business        
Sales to customers $ 5,730 4,632 $ 11,483 9,705
Percent Change (as a percent) 23.70%   18.30%  
PHARMACEUTICAL | Immunology        
Sales by segment of business        
Sales to customers $ 4,231 3,523 $ 8,145 7,161
Percent Change (as a percent) 20.10%   13.70%  
PHARMACEUTICAL | Immunology | U.S.        
Sales by segment of business        
Sales to customers $ 2,748 2,362 $ 5,161 4,772
Percent Change (as a percent) 16.40%   8.20%  
PHARMACEUTICAL | Immunology | International        
Sales by segment of business        
Sales to customers $ 1,483 1,161 $ 2,984 2,389
Percent Change (as a percent) 27.70%   24.90%  
PHARMACEUTICAL | Immunology | REMICADE®        
Sales by segment of business        
Sales to customers $ 888 935 $ 1,665 1,925
Percent Change (as a percent) (5.10%)   (13.50%)  
PHARMACEUTICAL | Immunology | REMICADE® | U.S.        
Sales by segment of business        
Sales to customers $ 540 593 $ 1,029 1,218
Percent Change (as a percent) (9.10%)   (15.60%)  
PHARMACEUTICAL | Immunology | REMICADE® | U.S. Exports        
Sales by segment of business        
Sales to customers $ 93 133 $ 150 243
Percent Change (as a percent) (30.00%)   (38.20%)  
PHARMACEUTICAL | Immunology | REMICADE® | International        
Sales by segment of business        
Sales to customers $ 255 208 $ 487 464
Percent Change (as a percent) 22.40%   4.90%  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA®        
Sales by segment of business        
Sales to customers $ 584 546 $ 1,146 1,075
Percent Change (as a percent) 6.90%   6.60%  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | U.S.        
Sales by segment of business        
Sales to customers $ 290 256 $ 545 528
Percent Change (as a percent) 12.80%   3.20%  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | International        
Sales by segment of business        
Sales to customers $ 294 289 $ 601 547
Percent Change (as a percent) 1.70%   9.80%  
PHARMACEUTICAL | Immunology | STELARA®        
Sales by segment of business        
Sales to customers $ 2,274 1,697 $ 4,422 3,516
Percent Change (as a percent) 34.00%   25.80%  
PHARMACEUTICAL | Immunology | STELARA® | U.S.        
Sales by segment of business        
Sales to customers $ 1,496 1,138 $ 2,827 2,355
Percent Change (as a percent) 31.40%   20.00%  
PHARMACEUTICAL | Immunology | STELARA® | International        
Sales by segment of business        
Sales to customers $ 778 558 $ 1,595 1,161
Percent Change (as a percent) 39.20%   37.30%  
PHARMACEUTICAL | Immunology | TREMFYA®        
Sales by segment of business        
Sales to customers $ 479 342 $ 897 638
Percent Change (as a percent) 40.20%   40.60%  
PHARMACEUTICAL | Immunology | TREMFYA® | U.S.        
Sales by segment of business        
Sales to customers $ 325 241 $ 599 428
Percent Change (as a percent) 35.00%   40.00%  
PHARMACEUTICAL | Immunology | TREMFYA® | International        
Sales by segment of business        
Sales to customers $ 155 101 $ 298 210
Percent Change (as a percent) 52.30%   41.80%  
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY        
Sales by segment of business        
Sales to customers $ 7 3 $ 15 6
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | U.S.        
Sales by segment of business        
Sales to customers 5 0 12 0
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | International        
Sales by segment of business        
Sales to customers $ 1 3 $ 3 6
Percent Change (as a percent) (61.30%)   (51.20%)  
PHARMACEUTICAL | Infectious Diseases        
Sales by segment of business        
Sales to customers $ 1,028 878 $ 2,035 1,798
Percent Change (as a percent) 17.10%   13.20%  
PHARMACEUTICAL | Infectious Diseases | U.S.        
Sales by segment of business        
Sales to customers $ 444 416 $ 956 852
Percent Change (as a percent) 6.80%   12.20%  
PHARMACEUTICAL | Infectious Diseases | International        
Sales by segment of business        
Sales to customers $ 585 463 $ 1,079 946
Percent Change (as a percent) 26.30%   14.10%  
PHARMACEUTICAL | Infectious Diseases | COVID-19        
Sales by segment of business        
Sales to customers $ 164 0 $ 264 0
PHARMACEUTICAL | Infectious Diseases | COVID-19 | U.S.        
Sales by segment of business        
Sales to customers 51 0 151 0
PHARMACEUTICAL | Infectious Diseases | COVID-19 | International        
Sales by segment of business        
Sales to customers 113 0 113 0
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine        
Sales by segment of business        
Sales to customers $ 262 256 $ 505 480
Percent Change (as a percent) 2.30%   5.20%  
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | U.S.        
Sales by segment of business        
Sales to customers $ 9 10 $ 19 22
Percent Change (as a percent) (9.30%)   (10.90%)  
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | International        
Sales by segment of business        
Sales to customers $ 253 246 $ 486 458
Percent Change (as a percent) 2.80%   6.00%  
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA®        
Sales by segment of business        
Sales to customers $ 505 510 $ 1,051 1,089
Percent Change (as a percent) (1.00%)   (3.50%)  
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | U.S.        
Sales by segment of business        
Sales to customers $ 368 379 $ 748 775
Percent Change (as a percent) (3.20%)   (3.50%)  
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | International        
Sales by segment of business        
Sales to customers $ 137 130 $ 303 314
Percent Change (as a percent) 5.50%   (3.50%)  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES        
Sales by segment of business        
Sales to customers $ 98 113 $ 215 229
Percent Change (as a percent) (13.00%)   (6.10%)  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | U.S.        
Sales by segment of business        
Sales to customers $ 16 25 $ 37 54
Percent Change (as a percent) (36.20%)   (31.30%)  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | International        
Sales by segment of business        
Sales to customers $ 81 87 $ 177 174
Percent Change (as a percent) (6.20%)   1.80%  
PHARMACEUTICAL | Neuroscience        
Sales by segment of business        
Sales to customers $ 1,808 1,587 $ 3,529 3,245
Percent Change (as a percent) 13.90%   8.70%  
PHARMACEUTICAL | Neuroscience | U.S.        
Sales by segment of business        
Sales to customers $ 842 778 $ 1,613 1,526
Percent Change (as a percent) 8.00%   5.60%  
PHARMACEUTICAL | Neuroscience | International        
Sales by segment of business        
Sales to customers $ 967 809 $ 1,916 1,719
Percent Change (as a percent) 19.60%   11.50%  
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate        
Sales by segment of business        
Sales to customers $ 161 149 $ 332 320
Percent Change (as a percent) 8.10%   3.90%  
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate | U.S.        
Sales by segment of business        
Sales to customers $ 35 55 $ 82 107
Percent Change (as a percent) (36.00%)   (23.10%)  
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate | International        
Sales by segment of business        
Sales to customers $ 127 94 $ 250 212
Percent Change (as a percent) 33.70%   17.50%  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA®        
Sales by segment of business        
Sales to customers $ 1,024 879 $ 1,989 1,762
Percent Change (as a percent) 16.40%   12.90%  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA® | U.S.        
Sales by segment of business        
Sales to customers $ 645 576 $ 1,234 1,120
Percent Change (as a percent) 11.90%   10.20%  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA® | International        
Sales by segment of business        
Sales to customers $ 380 303 $ 756 642
Percent Change (as a percent) 25.10%   17.70%  
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA®        
Sales by segment of business        
Sales to customers $ 155 153 $ 312 323
Percent Change (as a percent) 1.90%   (3.30%)  
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | U.S.        
Sales by segment of business        
Sales to customers $ 72 74 $ 139 150
Percent Change (as a percent) (3.00%)   (7.50%)  
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | International        
Sales by segment of business        
Sales to customers $ 84 79 $ 173 173
Percent Change (as a percent) 6.40%   0.40%  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE        
Sales by segment of business        
Sales to customers $ 468 406 $ 896 841
Percent Change (as a percent) 15.10%   6.50%  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | U.S.        
Sales by segment of business        
Sales to customers $ 91 75 $ 158 150
Percent Change (as a percent) 20.90%   5.60%  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | International        
Sales by segment of business        
Sales to customers $ 377 331 $ 738 691
Percent Change (as a percent) 13.80%   6.70%  
PHARMACEUTICAL | Oncology        
Sales by segment of business        
Sales to customers $ 3,535 2,791 $ 7,105 5,804
Percent Change (as a percent) 26.70%   22.40%  
PHARMACEUTICAL | Oncology | U.S.        
Sales by segment of business        
Sales to customers $ 1,462 1,181 $ 2,839 2,356
Percent Change (as a percent) 23.70%   20.50%  
PHARMACEUTICAL | Oncology | International        
Sales by segment of business        
Sales to customers $ 2,073 1,609 $ 4,266 3,448
Percent Change (as a percent) 28.80%   23.70%  
PHARMACEUTICAL | Oncology | DARZALEX®        
Sales by segment of business        
Sales to customers $ 1,433 901 $ 2,798 1,838
Percent Change (as a percent) 59.20%   52.20%  
PHARMACEUTICAL | Oncology | DARZALEX® | U.S.        
Sales by segment of business        
Sales to customers $ 770 492 $ 1,461 955
Percent Change (as a percent) 56.70%   53.10%  
PHARMACEUTICAL | Oncology | DARZALEX® | International        
Sales by segment of business        
Sales to customers $ 663 409 $ 1,337 883
Percent Change (as a percent) 62.10%   51.40%  
PHARMACEUTICAL | Oncology | ERLEADA        
Sales by segment of business        
Sales to customers $ 302 170 $ 563 313
Percent Change (as a percent) 77.60%   80.00%  
PHARMACEUTICAL | Oncology | ERLEADA | U.S.        
Sales by segment of business        
Sales to customers $ 193 136 $ 364 255
Percent Change (as a percent) 41.50%   42.70%  
PHARMACEUTICAL | Oncology | ERLEADA | International        
Sales by segment of business        
Sales to customers $ 109 33 $ 199 57
PHARMACEUTICAL | Oncology | IMBRUVICA®        
Sales by segment of business        
Sales to customers $ 1,116 949 $ 2,241 1,980
Percent Change (as a percent) 17.70%   13.20%  
PHARMACEUTICAL | Oncology | IMBRUVICA® | U.S.        
Sales by segment of business        
Sales to customers $ 454 447 $ 898 879
Percent Change (as a percent) 1.70%   2.20%  
PHARMACEUTICAL | Oncology | IMBRUVICA® | International        
Sales by segment of business        
Sales to customers $ 662 502 $ 1,342 1,101
Percent Change (as a percent) 31.90%   21.90%  
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate        
Sales by segment of business        
Sales to customers $ 563 568 $ 1,201 1,258
Percent Change (as a percent) (0.80%)   (4.50%)  
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate | U.S.        
Sales by segment of business        
Sales to customers $ 21 87 $ 71 226
Percent Change (as a percent) (75.30%)   (68.50%)  
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate | International        
Sales by segment of business        
Sales to customers $ 542 480 $ 1,130 1,032
Percent Change (as a percent) 12.80%   9.50%  
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY(1)        
Sales by segment of business        
Sales to customers $ 120 204 $ 302 416
Percent Change (as a percent) (40.90%)   (27.30%)  
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY(1) | U.S.        
Sales by segment of business        
Sales to customers $ 23 20 $ 44 42
Percent Change (as a percent) 18.80%   6.30%  
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY(1) | International        
Sales by segment of business        
Sales to customers $ 97 185 $ 258 375
Percent Change (as a percent) (47.20%)   (31.00%)  
PHARMACEUTICAL | Pulmonary Hypertension        
Sales by segment of business        
Sales to customers $ 870 789 $ 1,731 1,534
Percent Change (as a percent) 10.40%   12.90%  
PHARMACEUTICAL | Pulmonary Hypertension | U.S.        
Sales by segment of business        
Sales to customers $ 595 545 $ 1,168 1,031
Percent Change (as a percent) 9.00%   13.20%  
PHARMACEUTICAL | Pulmonary Hypertension | International        
Sales by segment of business        
Sales to customers $ 275 243 $ 563 503
Percent Change (as a percent) 13.50%   12.10%  
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT®        
Sales by segment of business        
Sales to customers $ 463 406 $ 913 795
Percent Change (as a percent) 14.10%   14.80%  
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | U.S.        
Sales by segment of business        
Sales to customers $ 290 256 $ 562 485
Percent Change (as a percent) 13.60%   15.90%  
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | International        
Sales by segment of business        
Sales to customers $ 172 150 $ 351 310
Percent Change (as a percent) 14.90%   13.10%  
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI®        
Sales by segment of business        
Sales to customers $ 313 282 $ 618 532
Percent Change (as a percent) 11.00%   16.20%  
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | U.S.        
Sales by segment of business        
Sales to customers $ 268 254 $ 527 466
Percent Change (as a percent) 6.00%   13.30%  
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | International        
Sales by segment of business        
Sales to customers $ 45 28 $ 91 66
Percent Change (as a percent) 54.90%   36.80%  
PHARMACEUTICAL | Pulmonary Hypertension | Other        
Sales by segment of business        
Sales to customers $ 95 101 $ 200 207
Percent Change (as a percent) (6.10%)   (3.30%)  
PHARMACEUTICAL | Pulmonary Hypertension | Other | U.S.        
Sales by segment of business        
Sales to customers $ 36 37 $ 78 81
Percent Change (as a percent) (2.40%)   (3.00%)  
PHARMACEUTICAL | Pulmonary Hypertension | Other | International        
Sales by segment of business        
Sales to customers $ 59 64 $ 122 126
Percent Change (as a percent) (8.20%)   (3.50%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other        
Sales by segment of business        
Sales to customers $ 1,126 1,184 $ 2,253 2,344
Percent Change (as a percent) (5.00%)   (3.90%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | U.S.        
Sales by segment of business        
Sales to customers $ 780 837 $ 1,579 1,643
Percent Change (as a percent) (6.90%)   (3.90%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | International        
Sales by segment of business        
Sales to customers $ 346 347 $ 674 701
Percent Change (as a percent) (0.30%)   (3.80%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO®        
Sales by segment of business        
Sales to customers $ 569 559 $ 1,158 1,086
Percent Change (as a percent) 1.80%   6.60%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | U.S.        
Sales by segment of business        
Sales to customers $ 569 559 $ 1,158 1,086
Percent Change (as a percent) 1.80%   6.60%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | International        
Sales by segment of business        
Sales to customers $ 0 0 $ 0 0
Percent Change (as a percent) 0.00%   0.00%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET®        
Sales by segment of business        
Sales to customers $ 160 179 $ 310 354
Percent Change (as a percent) (10.90%)   (12.60%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | U.S.        
Sales by segment of business        
Sales to customers $ 96 132 $ 183 249
Percent Change (as a percent) (27.00%)   (26.60%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | International        
Sales by segment of business        
Sales to customers $ 64 47 $ 127 105
Percent Change (as a percent) 33.80%   20.30%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX®        
Sales by segment of business        
Sales to customers $ 127 136 $ 254 291
Percent Change (as a percent) (6.60%)   (12.80%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | U.S.        
Sales by segment of business        
Sales to customers $ 59 70 $ 121 146
Percent Change (as a percent) (16.30%)   (17.30%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | International        
Sales by segment of business        
Sales to customers $ 69 66 $ 133 145
Percent Change (as a percent) 3.70%   (8.20%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | Other        
Sales by segment of business        
Sales to customers $ 271 312 $ 532 614
Percent Change (as a percent) (13.00%)   (13.30%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | Other | U.S.        
Sales by segment of business        
Sales to customers $ 57 78 $ 117 163
Percent Change (as a percent) (26.70%)   (27.80%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | Other | International        
Sales by segment of business        
Sales to customers $ 214 234 $ 415 451
Percent Change (as a percent) (8.40%)   (8.10%)  
MEDICAL DEVICES        
Sales by segment of business        
Sales to customers $ 6,978 4,288 $ 13,557 10,220
Percent Change (as a percent) 62.70%   32.70%  
MEDICAL DEVICES | U.S.        
Sales by segment of business        
Sales to customers $ 3,299 1,862 $ 6,353 4,760
Percent Change (as a percent) 77.20%   33.50%  
MEDICAL DEVICES | International        
Sales by segment of business        
Sales to customers $ 3,679 2,426 $ 7,204 5,460
Percent Change (as a percent) 51.60%   31.90%  
MEDICAL DEVICES | Interventional Solutions        
Sales by segment of business        
Sales to customers $ 1,046 590 $ 1,995 1,317
Percent Change (as a percent) 77.40%   51.50%  
MEDICAL DEVICES | Interventional Solutions | U.S.        
Sales by segment of business        
Sales to customers $ 475 255 $ 909 620
Percent Change (as a percent) 86.50%   46.70%  
MEDICAL DEVICES | Interventional Solutions | International        
Sales by segment of business        
Sales to customers $ 572 335 $ 1,086 697
Percent Change (as a percent) 70.50%   55.70%  
MEDICAL DEVICES | Orthopaedics        
Sales by segment of business        
Sales to customers $ 2,227 1,451 $ 4,340 3,489
Percent Change (as a percent) 53.40%   24.40%  
MEDICAL DEVICES | Orthopaedics | U.S.        
Sales by segment of business        
Sales to customers $ 1,323 869 $ 2,572 2,119
Percent Change (as a percent) 52.30%   21.40%  
MEDICAL DEVICES | Orthopaedics | International        
Sales by segment of business        
Sales to customers $ 904 583 $ 1,768 1,371
Percent Change (as a percent) 55.10%   29.00%  
MEDICAL DEVICES | Orthopaedics | HIPS        
Sales by segment of business        
Sales to customers $ 392 226 $ 749 563
Percent Change (as a percent) 73.70%   33.00%  
MEDICAL DEVICES | Orthopaedics | HIPS | U.S.        
Sales by segment of business        
Sales to customers $ 234 137 $ 444 343
Percent Change (as a percent) 70.50%   29.60%  
MEDICAL DEVICES | Orthopaedics | HIPS | International        
Sales by segment of business        
Sales to customers $ 159 88 $ 305 220
Percent Change (as a percent) 78.60%   38.30%  
MEDICAL DEVICES | Orthopaedics | KNEES        
Sales by segment of business        
Sales to customers $ 350 174 $ 667 517
Percent Change (as a percent)     28.90%  
MEDICAL DEVICES | Orthopaedics | KNEES | U.S.        
Sales by segment of business        
Sales to customers $ 210 108 $ 395 322
Percent Change (as a percent) 94.30%   22.70%  
MEDICAL DEVICES | Orthopaedics | KNEES | International        
Sales by segment of business        
Sales to customers $ 140 66 $ 272 196
Percent Change (as a percent)     39.20%  
MEDICAL DEVICES | Orthopaedics | TRAUMA        
Sales by segment of business        
Sales to customers $ 710 553 $ 1,443 1,207
Percent Change (as a percent) 28.40%   19.60%  
MEDICAL DEVICES | Orthopaedics | TRAUMA | U.S.        
Sales by segment of business        
Sales to customers $ 447 354 $ 897 761
Percent Change (as a percent) 26.00%   17.80%  
MEDICAL DEVICES | Orthopaedics | TRAUMA | International        
Sales by segment of business        
Sales to customers $ 263 198 $ 545 445
Percent Change (as a percent) 32.70%   22.50%  
MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS & OTHER        
Sales by segment of business        
Sales to customers $ 776 499 $ 1,482 1,202
Percent Change (as a percent) 55.30%   23.20%  
MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS & OTHER | U.S.        
Sales by segment of business        
Sales to customers $ 433 270 $ 836 693
Percent Change (as a percent) 60.60%   20.70%  
MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS & OTHER | International        
Sales by segment of business        
Sales to customers $ 343 230 $ 646 510
Percent Change (as a percent) 49.00%   26.70%  
MEDICAL DEVICES | Surgery        
Sales by segment of business        
Sales to customers $ 2,522 1,551 $ 4,894 3,651
Percent Change (as a percent) 62.60%   34.00%  
MEDICAL DEVICES | Surgery | U.S.        
Sales by segment of business        
Sales to customers $ 1,035 490 $ 1,933 1,334
Percent Change (as a percent)     44.90%  
MEDICAL DEVICES | Surgery | International        
Sales by segment of business        
Sales to customers $ 1,487 1,060 $ 2,961 2,317
Percent Change (as a percent) 40.20%   27.80%  
MEDICAL DEVICES | Surgery | ADVANCED        
Sales by segment of business        
Sales to customers $ 1,168 775 $ 2,286 1,723
Percent Change (as a percent) 50.50%   32.60%  
MEDICAL DEVICES | Surgery | ADVANCED | U.S.        
Sales by segment of business        
Sales to customers $ 459 277 $ 864 658
Percent Change (as a percent) 65.40%   31.30%  
MEDICAL DEVICES | Surgery | ADVANCED | International        
Sales by segment of business        
Sales to customers $ 708 498 $ 1,421 1,065
Percent Change (as a percent) 42.20%   33.40%  
MEDICAL DEVICES | Surgery | GENERAL        
Sales by segment of business        
Sales to customers $ 1,354 775 $ 2,608 1,928
Percent Change (as a percent) 74.70%   35.30%  
MEDICAL DEVICES | Surgery | GENERAL | U.S.        
Sales by segment of business        
Sales to customers $ 576 213 $ 1,069 676
Percent Change (as a percent)     58.10%  
MEDICAL DEVICES | Surgery | GENERAL | International        
Sales by segment of business        
Sales to customers $ 779 562 $ 1,540 1,252
Percent Change (as a percent) 38.50%   23.00%  
MEDICAL DEVICES | Vision        
Sales by segment of business        
Sales to customers $ 1,183 695 $ 2,328 1,762
Percent Change (as a percent) 70.10%   32.10%  
MEDICAL DEVICES | Vision | U.S.        
Sales by segment of business        
Sales to customers $ 467 248 $ 939 687
Percent Change (as a percent) 88.30%   36.60%  
MEDICAL DEVICES | Vision | International        
Sales by segment of business        
Sales to customers $ 716 447 $ 1,389 1,075
Percent Change (as a percent) 60.00%   29.20%  
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER        
Sales by segment of business        
Sales to customers $ 868 554 $ 1,725 1,368
Percent Change (as a percent) 56.70%   26.10%  
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | U.S.        
Sales by segment of business        
Sales to customers $ 352 203 $ 723 549
Percent Change (as a percent) 73.30%   31.60%  
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | International        
Sales by segment of business        
Sales to customers $ 517 352 $ 1,003 819
Percent Change (as a percent) 47.00%   22.50%  
MEDICAL DEVICES | Vision | SURGICAL        
Sales by segment of business        
Sales to customers $ 314 141 $ 602 394
Percent Change (as a percent)     52.80%  
MEDICAL DEVICES | Vision | SURGICAL | U.S.        
Sales by segment of business        
Sales to customers 115 45 $ 216 138
Percent Change (as a percent)     56.30%  
MEDICAL DEVICES | Vision | SURGICAL | International        
Sales by segment of business        
Sales to customers $ 199 $ 96 $ 386 $ 256
Percent Change (as a percent)     50.90%